- JBS’ adjusted EBITDA for Q2 was R$9.88 billion, significantly higher than the R$4.47 billion from the previous year, beating the estimate of R$7.91 billion.
- Seara’s adjusted EBITDA rose to R$2.02 billion from R$419.9 million in the previous year, surpassing the estimate of R$1.4 billion.
- JBS Brasil reported an adjusted EBITDA of R$1.18 billion, a 75% increase year-over-year, beating the forecast of R$820.9 million.
- JBS North America Beef saw a drop in adjusted EBITDA to R$151.3 million, a 65% decrease year-over-year, though it still exceeded the estimate of R$135 million.
- JBS USA Pork’s adjusted EBITDA surged to R$1.25 billion from R$386.3 million in the previous year, well above the estimate of R$1.05 billion.
- JBS Australia’s adjusted EBITDA increased by 66% year-over-year to R$1.18 billion, surpassing the estimate of R$843.1 million.
- Pilgrim’s Pride achieved an adjusted EBITDA of R$4.08 billion, up from R$1.86 billion year-over-year, beating the estimate of R$3.23 billion.
- Net income for the quarter was R$1.72 billion, a dramatic improvement from a loss of R$263.6 million last year, but below the estimate of R$2.17 billion.
- Net revenue came in at R$100.61 billion, a 13% increase year-over-year, exceeding the estimate of R$97.35 billion.
- Seara’s net revenue was R$11.59 billion, a 12% year-over-year increase, beating the forecast of R$10.66 billion.
- JBS Brasil’s net revenue jumped to R$15.55 billion, an 11% rise year-over-year, exceeding the estimate of R$14.18 billion.
- JBS North America Beef reported net revenue of R$31.26 billion, up 8.7% year-over-year, surpassing the estimate of R$28.47 billion.
- JBS USA Pork’s net revenue surged by 28% year-over-year to R$11.28 billion, beating the forecast of R$9.85 billion.
- JBS Australia’s net revenue increased by 15% year-over-year to R$8.62 billion, above the estimate of R$7.95 billion.
- Pilgrim’s Pride’s net revenue rose to R$23.77 billion, a 12% increase year-over-year, narrowly exceeding the estimate of R$23.68 billion.
- Overall EBITDA more than doubled from the previous year to R$8.77 billion, compared to R$4.18 billion.
- The adjusted EBITDA margin was 9.8%, above the expected 8.59%.
- Net debt grew to R$82.05 billion, a 2.2% increase year-over-year but slightly higher than the estimate of R$77.99 billion.
- Net debt to EBITDA ratio decreased by 21% year-over-year to 3.06 times.
- The company received a positive outlook from analysts with 18 buys, 1 hold, and 0 sells recommendations.
A look at JBS S/A Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 4 | |
| Growth | 2 | |
| Resilience | 2 | |
| Momentum | 5 | |
| OVERALL SMART SCORE | 3.2 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Analysts at Smartkarma have provided a comprehensive outlook for JBS S.A., a leading meat processor. With a strong momentum score of 5, JBS is showing robust performance in the market. This indicates a positive trend that may continue in the long term. Additionally, the company has been rated highly for its dividend with a score of 4, showcasing its commitment to rewarding investors.
Although JBS has received lower scores for growth and resilience at 2, suggesting there may be areas for improvement, its value score of 3 indicates a fair valuation. Overall, with a balanced mix of scores, JBS S.A. presents itself as a company with promising potential in the meat processing industry, both in terms of financial performance and investor returns.
Summary: JBS S.A. operates as a processor of various meats, including beef, pork, lamb, and chicken, along with hides. The company has a global presence through its product exports, positioning itself as a significant player in the meat processing sector.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
